Clinical Trials Browser

Phase 1 × XL647 × Clear all

NCT00086528 2022-05-13

Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors

Phase 1 Completed

Neoplasms

NCT00336765 2022-05-13

Study of XL647 Administered Orally Daily to Patients With Solid Tumors

Phase 1 Completed

Neoplasms

NCT00704392 2015-08-20

Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors

Phase 1 Withdrawn

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms